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Conclusion: Proton-beam grids with 3 mm beam elements 
produce dose distributions in water for which the grid pattern 
is preserved down to large depths. PBGT could be carried out 
at proton therapy centers, equipped with spot-scanning 
possibilities, using existing tools. However, smaller beams 
than those currently available could be advantageous for 
biological reasons. With PBGT, it is also possible to create a 
more uniform target dose than what has been possible to 
produce with photon-beam grids. We anticipate that PBGT 
could be a useful technique to reduce both short- and long-
term side effects after radiotherapy. 
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Purpose or Objective: Currently, various MR-guided 
radiotherapy systems are being developed and clinically 
implemented. For conventional radiotherapy, Electronic 
Portal Imaging Devices (EPIDs) are frequently used for in vivo 
dose verification. The high complexity of online treatment 
adaptation makes independent dosimetric verification in the 
Elekta MR-linac combination indispensable. One of the 
challenges for MR-linac portal dosimetry is the presence of 
the MRI housing between the patient and the EPID. 
The purpose of this study was to adapt our previously 
developed back-projection algorithm for the presence of the 
MRI scanner. 
 
Material and Methods: Three steps have been added to our 
current EPID dosimetry back-projection model to account for 
the presence of the MRI scanner: i) subtraction of scatter 
from the MRI to the EPID, ii) correction for the MRI 
attenuation, iii) compensation for changes in the beam 
spectrum. The calibration of the algorithm needs a set of 
commissioning data (from EPID and ionization chamber, both 
with and without the MRI) to determine the parameters for 
the back-projection method. 
An aluminum block of 12 cm thickness at 15 cm distance from 
the EPID was used to approximate the effects of the MRI 
scanner. Measurements were performed using a 6MV photon 
beam of a conventional SL20i linear accelerator (Elekta AB, 
Stockholm, Sweden) at 0° gantry. 
58 IMRT fields of 11 plans (H&N, lung, prostate and rectum) 
were delivered to a 20 cm polystyrene slab phantom and 
portal images were acquired with the aluminum plate in 
place. For independent comparison with our conventional 
method the same fields were delivered without the aluminum 
plate. The EPID images were converted to dose, corrected for 
the presence of the aluminum plate, back-projected into the 
phantom and compared to the planned dose distribution 
using a 2-D gamma evaluation (3%, 3 mm). 
 
Results: The γ_mean averaged over the 58 IMRT fields was 
0.39±0.11, the γ_1% was 1.05±0.30 and the %_γ≤1 was 
95.7±5.3. The dose difference at the isocenter was -0.7±2.2 
cGy. These results are in close agreement with the 
performance of our algorithm for the conventional linac 
setup (Table 1). 
 
 
 
Conclusion: Our EPID dosimetry back projection algorithm 
was successfully adapted for the presence of an attenuating 
medium between phantom (or patient) and EPID. 
Experiments using a 12 cm aluminum plate (approximating 
the MR-linac geometry) showed excellent agreement 
between planned and EPID reconstructed dose distributions. 
This result is an essential step towards an accurate, 
independent, and potentially fast field-by-field IMRT portal 
dosimetry based verification tool for the MR-linac. 
Part of this research was sponsored by Elekta AB.  
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Purpose or Objective: Hyperthermia is a (neo)adjuvant 
treatment modality that increases the effectiveness of 
radiotherapy or chemotherapy by heating the tumour area to 
41–43 °C. Loco-regional hyperthermia is delivered using 
phased array systems with individually controlled antennae. 
Hyperthermia treatment planning is necessary to determine 
the phase and amplitude settings for the individual antennae 
that result in the optimal temperature distribution. Current 
treatment planning systems are accurate for solid tissues but 
ignore the specific properties of the urinary bladder and its 
contents, which limits their accuracy in the pelvic region. 
This may have clinical implications for such treatment sites 
as the rectum, the cervix uteri, and the bladder itself.  
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The aim of this study is to incorporate a physically correct 
description of the bladder properties in treatment planning, 
most notably the presence of convection and the absence of 
perfusion, and to assess the differences with the 
conventional model. 
 
Material and Methods: We created a convective 
thermophysical fluid model based on the Boussinesq 
approximation to the Navier-Stokes equations; this means we 
assumed all parameters to be temperature independent 
except for the mass density in the gravitational term. We 
implemented this using the (finite element) OpenFOAM 
toolkit, and coupled it to our (finite difference) in-house 
developed treatment planning system, based on Pennes’ bio-
heat equation. 
A CT scan was obtained from a bladder cancer patient and an 
experienced clinician delineated the bladder as part of the 
standard clinical work-flow. Based on this input, we first 
performed the treatment planning the conventional way with 
a muscle-like solid bladder, and calculated the optimal phase 
and amplitude settings for all four antennae. Next, we redid 
the temperature calculation with the expanded treatment 
planning system with a fluid-filled bladder, using the same 
settings. We subsequently calculated the differences 
between the two temperature distributions. 
 
Results: The temperature in the bladder with realistic fluid 
modelling is much higher than without, as the absence of 
perfusion in the bladder filling leads to a much lower heat 
removal. The maximum temperature difference was 3.6 °C. 
Clinically relevant tissue temperature differences of more 
than 0.5 °C extended to 1.75 cm around the bladder. The 
temperature distribution according to the convective model 
and the difference with the solid only model are shown in 
Figure 1. The difference reflects the homogenizing effect of 
convection within the bladder and the nett heat transport in 
the upward direction. 
 
 
 
Conclusion: The addition of the new convective model to the 
hyperthermia treatment planning system leads to clinically 
highly relevant temperature changes. Explicit modelling of 
fluids is particularly important when the bladder or its direct 
surroundings are part of the treatment target area. 
 
 
Proffered Papers: Physics 14: Treatment planning: 
applications II  
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Purpose or Objective: There have been concerns that the 
quality of highly conformal dose distributions, delivered 
under active MRI guidance, may be degraded by the influence 
of the magnetic field on secondary electrons. This planning 
study quantifies this effect for stereotactic body 
radiotherapy (SBRT) of lung tumors, conducted either with or 
without real-time multileaf collimator (MLC) tumor tracking. 
 
Material and Methods: The Elekta Monaco treatment 
planning software, research version 5.09.07, was used to 
design treatment plans on the peak-exhale 4DCT phase of 
nine patients undergoing lung SBRT. The software features a 
machine model of the Atlantic MR-linac system and allows 
dose calculation and plan optimization under consideration of 
a magnetic field. 
For each patient, we prepared four different 9-beam step-
and-shoot IMRT plans: two for conventional, non-tracked 
treatment and two for delivery with real-time MLC tumor 
tracking, each delivered either with or without a 1.5T 
magnetic field oriented in the superior-inferior patient 
direction. For the conventional delivery, the internal target 
volume was defined as the union of the gross tumour volumes 
(GTV), delineated on each 4DCT phase. For the tracked 
delivery, the moving target volume was defined as union of 
all GTVs, each corrected for the center-of-volume shift thus 
accounting for target deformations. Dose was prescribed 
according to the RTOG 1021 guideline. Delivery of the 
respective plans was simulated to all 4DCT phases and the 
doses were then deformably accumulated onto the peak-
exhale phase. 
In order to evaluate the effect of the magnetic field and real-
time tumor tracking, several dose-volume metrics and the 
integral deposited energy in the body were compared. 
Statistical significance of the differences was evaluated using 
a two-sided paired t-test after verifying normal distribution 
of them, while correcting for multiple testing for the four 
primary endpoints. 
 
Results: The table presents the differences in the 
investigated dose-volume metrics due to either the presence 
of a magnetic field or real-time MLC tumor tracking. Most 
prominently, the magnetic field caused an increase in dose to 
the skin and a decrease of dose to the GTV (see figure). 
While statistically significant, the magnitude of these 
differences is small. In all 36 simulated dose deliveries, the 
dose prescription to the target was fulfilled and there were 
only minor violations of normal tissue constraints.  
Real-time MLC tumor tracking was able to maintain dose 
coverage of the GTV while reducing the integral deposited 
energy. This results in a decrease in dose to the skin and 
normal lung tissue, both with and without a magnetic field. 
